PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research Spotlight: Mapping overlooked challenges in stroke recovery

Nirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scal

2025-10-17
(Press-News.org) Nirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scale.”

Q: How would you summarize your study for a lay audience?

As doctors who care for stroke survivors, we recognize that recovery is a long journey shaped by physical, emotional, mental and social challenges that extend beyond the hospital walls. We also recognize that many changes are needed to help all stroke survivors achieve their best recovery, which means optimizing both their health and their wellbeing. The first step to improving stroke recovery is understanding the lived experiences of stroke survivors and their care partners.

We conducted one of the largest qualitative studies with stroke survivors and care partners within the United States to better understand what wellbeing means in recovery. Through the lived experiences that participants shared with us, we identified key factors that shape physical and emotional wellbeing after stroke.

While medical care usually focuses on building physical strength and improving movement, stroke survivors struggle with additional emotional challenges such as facing stigma, living with uncertainty, and losing a part of their identity. Our study highlights the importance of integrating stroke survivors’ lived experiences in stroke research and provides a foundation for evaluating the nonclinical determinants that shape health, wellbeing and recovery.

Q: What was the main goal of your study?

Our goal was to understand the factors that shape physical and emotional wellbeing after stroke — as described by stroke survivors — and to assess whether the questionnaires that we commonly use in research or at the doctor’s office effectively capture all of these elements.

Q: What methods or approach did you use?

We applied qualitative research methods and studied the experiences of 41 stroke survivors and caregivers across the U.S. from October 2023 until December 2024.

We met stroke survivors and caregivers in small groups and asked them about their experiences related to physical and emotional wellbeing during recovery. We also compared stroke survivors’ experiences with questions included in the Stroke Specific Quality of Life or the SSQoL survey, which is commonly used by doctors and researchers. By comparing the two methodologies, we identified factors related to physical and emotional wellbeing that are well-represented in traditional medical care, and those areas that may be overlooked.

Q: What did you find?

We found that stroke recovery is shaped by more than physical factors — stroke survivors shared that their emotional recovery is just as important. We found five key factors of reduced physical functioning and social participation: the loss of independence, the fear of uncertainty, reduced community participation, feelings of shame and decreased physical mobility.

 On comparing these factors to the SSQoL, we found that the SSQoL adequately captured some of these factors, but only partially captured other important factors like shame and uncertainty. Our study highlights a potential care gap in how stroke clinicians can address recovery for stroke survivors.  

Q: What are the implications?

The implications of these findings are twofold. First, we have partnered with stroke survivors to identify their priorities that clinicians should address during follow-up care. Second, we have identified gaps in measuring these priorities, highlighting the need for alternative care models that address recovery in a more comprehensive way.

Q: What are the next steps?

The next steps are to use these findings to develop interventions that address more than physical recovery in stroke care, and are developed with patient and care partner input. We believe a key component that has been missing from stroke research is understanding the lived experiences of stroke survivors.

We would like to thank all of the stroke survivors and care partners who collaborated with our group for this research study. Their willingness to help other stroke survivors, their honesty in sharing their stories, and their resilience in recovery has been inspiring for our team to continue this important work.

Authorship: In addition to Nirupama Yechoor, co-authors include Devanshi Choksi, Mary Craven, Taylor McVeigh, Akashleena Mallick, Tanzeela Ranman, Christina Kourkoulis, Sofia Constantinescu, Rachel Kitagawa, Emilie Egger, Lindsay Rosenfeld, Rachel Forman, Guido J. Falcone, Jonathan Rosand, and Vanessa L. Merker.

Paper cited: Choksi, D., et al. “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scale” JAMA Network Open. DOI: 10.1001/jamanetworkopen.2025.3795

Funding: This work was supported by grants from the Bugher Collaborative Project (PI, Dr. Falcone; No. 23BFHSCP1178409; Dr. Rosand; No. 23BFHSCP1176239).

Disclosures: D. Choksi is supported by the Lavine Brain Health Innovation Fund. G.J. Falcone is supported by the AHA (817874, 24GWTGSIC1341098, 23BFHSCP1178409) and the NIH (P30AG021342, U01NS106513, RF1NS139183). J. Rosand has a leadership or fiduciary role at Columbia University, Lancet Neurology, and European Stroke Journal.

END


ELSE PRESS RELEASES FROM THIS DATE:

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

2025-10-17
About The Study: The findings of this study suggest that despite increasing screening overall, which led to reduced geographic variation in screening, local clusters of high and low screening persisted in the Northeast and Southwest U.S., respectively. Future studies could incorporate county-level health care access characteristics to explain why areas of low screening did not catch up to optimize cancer screening practices.  Corresponding Author: To contact the corresponding author, Timothy R. Rebbeck, PhD, email timothy_rebbeck@dfci.harvard.edu. To access the ...

Cannabis laws and opioid use among commercially insured patients with cancer diagnoses

2025-10-17
About The Study: This study’s findings indicate cannabis may be a substitute for opioids in the management of cancer-related pain. However, further research directly observing cannabis use is needed to evaluate the efficacy of cannabis as a treatment for cancer-related pain. Corresponding Author: To contact the corresponding author, Victoria Bethel, MSN, email vbethel@uga.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2025.3512) Editor’s Note: Please see the article ...

Research Spotlight: Surprising gene mutation in brain’s immune cells linked to increased Alzheimer’s risk

2025-10-17
Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, “The Gain-of-Function TREM2-T96K Mutation Increases Risk for Alzheimer’s Disease by Impairing Microglial Function.” Q: How would you summarize your study for a lay audience? Our team wanted to understand how immune cells of the brain, called microglia, contribute to Alzheimer’s disease (AD) pathology. It’s known that subtle changes, or mutations, in genes expressed in microglia are associated with an increased ...

Missing molecule may explain Down syndrome

2025-10-17
Faulty brain circuits seen in Down syndrome may be caused by the lack of a particular molecule essential for the development and function of the nervous system, new research suggests. Restoring the molecule, called pleiotrophin, could improve brain function in Down syndrome and other neurological diseases – possibly even in adults, the researchers say. The scientists conducted their work in lab mice, rather than in people, so the approach is far from being available as a treatment. But the researchers found that administering pleiotrophin improved brain function in adult ...

Donor diabetes and 1-year Descemet membrane endothelial keratoplasty success rate

2025-10-17
About The Study: The 1-year success rate in eyes undergoing Descemet membrane endothelial keratoplasty (DMEK) with successfully prepared tissue was very high regardless of donor diabetes status. These results, supported by the separately reported finding that endothelial cell loss and cornea morphometry after 1 year were not affected by donor diabetes status, provide strong support for having no restrictions on the use of tissue from donors with diabetes for DMEK.  Corresponding Author: To contact the corresponding author, Jonathan H. Lass, MD, email deks@case.edu. To access the embargoed study: Visit our For The Media website at this link ...

Endothelial cell loss 1 year after successful DMEK in the diabetes endothelial keratoplasty study

2025-10-17
About The Study: This randomized clinical trial found that endothelial cell loss and morphometry 1 year after Descemet membrane endothelial keratoplasty (DMEK) were not affected by cornea donor diabetes status. With comparable 1-year graft success with tissue from donors with and without diabetes demonstrated in this trial, these findings support the use of corneas from donors with diabetes for endothelial keratoplasty procedures.  Corresponding Author: To contact the corresponding author, Jonathan ...

Overactive Runx1 gene triggers early disc degeneration linked to aging

2025-10-17
“Taken together, these findings reveal a novel role of Runx1 in maintaining disc health and regulating age-related degenerative processes.” BUFFALO, NY — October 17, 2025 — A new research paper was published in Volume 17, Issue 9 of Aging-US on September 8, 2025, titled, “Runx1 overexpression induces early onset of intervertebral disc degeneration.” In this study, led by first author Takanori Fukunaga from Emory University School of Medicine and corresponding author Hicham Drissi from Emory and the Atlanta VA Medical Center, researchers found that the Runx1 gene, when overactive in spinal disc cells, ...

NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025

2025-10-17
ORLANDO, FLORIDA, OCTOBER 17, 2025—NYU Langone Health ophthalmology faculty present their latest research at this year’s annual meeting of the American Academy of Ophthalmology (AAO), where Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor and chair of the Department of Ophthalmology at NYU Grossman School of Medicine, will be awarded the prestigious Castroviejo Medal from the Cornea Society. This honor recognizes Dr. Colby’s groundbreaking contributions to the field of ophthalmology, particularly in the promotion, research, and understanding of the cornea. Among the presentations at AAO in Orlando, October 17 ...

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

2025-10-17
BERLIN October 17, 2025 – Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed EGFR-mutated advanced non-small cell lung cancer (NSCLC) compared to osimertinib alone. The finding is based on an analysis of the complete data from the phase 3 global FLAURA2 study, co-led by researchers from Dana-Farber Cancer Institute and Gustave Roussy (Grand Paris, Villejuif, France). Median overall survival was 47.5 months in the osimertinib plus platinum–pemetrexed group versus 37.6 months ...

FAU’s Queen Conch Lab receives prestigious international award

2025-10-17
The Florida Atlantic University Harbor Branch Oceanographic Institute’s Queen Conch Lab, led by research professor Megan Davis, Ph.D., has been named the recipient of the 2025 Responsible Seafood Innovation Award in Aquaculture from the Global Seafood Alliance (GSA). The award honors the Queen Conch Lab’s development of mobile lab hatcheries designed to help restore the threatened Caribbean queen conch. These self-contained, trailer-based hatcheries bring advanced aquaculture capabilities to coastal communities across the Caribbean, many of which lack traditional infrastructure. This innovation is not only helping to rebuild wild ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Research Spotlight: Mapping overlooked challenges in stroke recovery
Nirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scal